![](/img/cover-not-exists.png)
Empagliflozin, an SGLT2 inhibitor, reduced the mortality rate after acute myocardial infarction with modification of cardiac metabolomes and anti-oxidants in diabetic rats.
Oshima, Hiroto, Miki, Takayuki, Kuno, Atsushi, Mizuno, Masashi, Sato, Tatsuya, Tanno, Masaya, Yano, Toshiyuki, Nakata, Kei, Kimura, Yukishige, Abe, Koki, Ohwada, Wataru, Miura, TetsujiLanguage:
english
Journal:
Journal of Pharmacology and Experimental Therapeutics
DOI:
10.1124/jpet.118.253666
Date:
December, 2018
File:
PDF, 1.61 MB
english, 2018